Higher Rates of Mortality but Not Morbidity Follow Intracranial Mechanical Thrombectomy in the Elderly

References

1. 1.↵
   1. Gobin YP,
   2. Starkman S,
   3. Duckwiler GR,
   4. et al

   . MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848–54

   Abstract/FREE Full Text
2. 2.↵
   1. Smith WS,
   2. Sung G,
   3. Starkman S,
   4. et al.

   , for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

   Abstract/FREE Full Text
3. 3.↵
   1. Day J

   . Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995–2050. Washington, DC: US Bureau of the Census; 1996. Current Population Reports, Series P25–1130
4. 4.↵
   1. Brown RD,
   2. Whisnant JP,
   3. Sicks JD,
   4. et al

   . Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373–80

   PubMedWeb of Science
5. 5.↵
   1. Sharma JC,
   2. Fletcher S,
   3. Vassallo M

   . Strokes in the elderly: higher acute and 3 month mortality—an explanation. Cerebrovasc Dis 1999;9:2–9

   PubMedWeb of Science
6. 6.↵
   1. Arnold M,
   2. Schroth G,
   3. Nedeltchev K,
   4. et al

   . Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828–33

   Abstract/FREE Full Text
7. 7.↵
   1. Kim D,
   2. Ford GA,
   3. Kidwell CS,
   4. et al

   . Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neurorad 2007;28:159–63
8. 8.↵
   1. Tanne D,
   2. Gorman M,
   3. Bates V,
   4. et al

   . Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the TPA stroke survey experience. Stroke 2000;31:370–75

   Abstract/FREE Full Text
9. 9.↵
   1. Khatri P,
   2. Neff J,
   3. Broderick JP,
   4. et al.

   , for the IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400–03

   Abstract/FREE Full Text
10. 10.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al.

    , for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Kim D,
    2. Jahan R,
    3. Saver JL,
    4. et al.

    , for the MERCI and Multi MERCI Investigators. Mechanical thrombectomy with the Merci retriever for acute stroke in very elderly patients. In: Proceedings of the Fourth Annual Meeting of the American Society of Interventional and Therapeutic Neuroradiology, Dana Point, California, August 1, 2007
12. 12.↵
    1. Furlan A,
    2. Higashida R,
    3. Weschler L,
    4. et al

    . Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Kidwell CS,
    2. Saver JL,
    3. Carneado J,
    4. et al

    . Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33:717–24

    Abstract/FREE Full Text
14. 14.↵
    1. Kase CS,
    2. Furlan AJ,
    3. Wechsler LR,
    4. et al

    . Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–10

    Abstract/FREE Full Text
15. 15.↵
    1. Tanne D,
    2. Kasner SE,
    3. Demchuk AM,
    4. et al

    . Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679–85

    Abstract/FREE Full Text
16. 16.↵
    1. Larrue V,
    2. von Kummer RR,
    3. Müller A,
    4. et al

    . Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438–41

    Abstract/FREE Full Text
17. 17.↵
    1. Bang OY,
    2. Saver JL,
    3. Buck BH,
    4. et al.

    , for the UCLA Collateral Investigators. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625–29. Epub 2007 Dec 12

    Abstract/FREE Full Text
18. 18.↵
    1. Christoforidis GA,
    2. Karakasis C,
    3. Mohammad Y,
    4. et al

    . Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol 2009;30:165–70

    Abstract/FREE Full Text
19. 19.↵
    1. Nedelmann M,
    2. Wilhelm-Schwenkmezger T,
    3. Alessandri B,
    4. et al

    . Cerebral embolic ischemia in rats: correlation of stroke severity and functional deficit as important outcome parameter. Brain Res 2007;1130:188–96. Epub 2006 Dec 8

    CrossRefPubMed
20. 20.↵
    1. Nighoghossian N,
    2. Hermier M,
    3. Adeleine P,
    4. et al

    . Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003;34:458–63

    Abstract/FREE Full Text
21. 21.↵
    1. Tomsick T

    . TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28:382–84

    FREE Full Text
22. 22.↵
    1. Higashida R,
    2. Furlan A,
    3. Roberts H,
    4. et al.

    , for the Technology Assessment Committees of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14:945–46

    PubMed
23. 23.↵
    1. Tejima E,
    2. Katayama Y,
    3. Suzuki Y,
    4. et al

    . Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke 2001;32:1336–40

    Abstract/FREE Full Text
24. 24.↵
    1. Elewa HF,
    2. Kozak A,
    3. Johnson MH,
    4. et al

    . Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens 2007;25:855–59

    PubMed
25. 25.↵
    1. Greer DM,
    2. Funk SE,
    3. Reaven NL,
    4. et al

    . Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 2008;39:3029–35

    Abstract/FREE Full Text